2.1. Study location
IBD, UC
The study was carried out at a public outpatient pharmacy unit (POP) responsible for dispensing medications to patients with different health conditions, including patients with IBD. The study site was in the city of Salvador, capital of the state of Bahia, Brazil. At that time UC patients had access exclusively to oral (mesalamine, sulfasalazine, azathioprine, cyclosporine) and rectal treatment (mesalamine). In 2019, the unit had 855 patients with UC registered for care, including 590 users assisted by physicians from the public health system and 265 from the complementary health system.